Liraglutide, developed by Amber Lifesciences, functions as a GLP-1 receptor agonist. It is primarily used for managing type 2 diabetes and assisting in weight loss. By enhancing insulin secretion and suppressing appetite, it effectively controls blood sugar levels and promotes weight reduction. Administered through subcutaneous injections Amber Lifesciences Pvt Ltd liraglutide improves glycemic control and aids in obesity management by reducing hunger and caloric intake. Its multifaceted actions also include slowing gastric emptying and stimulating insulin release in response to elevated blood glucose levels.